A federal judge in Los Angeles on Thursday sentenced Kenneth Iwamasa, the personal assistant of the late actor Matthew Perry, to 15 months in prison for his role in orchestrating the ketamine injections that led to Perry's death in October 2023. Iwamasa, 59, pleaded guilty in August to one count of conspiracy to distribute ketamine. The sentencing marks a pivotal moment in a case that has drawn attention to the unchecked infiltration of high-dose recreational ketamine into Hollywood circles and sparked renewed calls in the United Kingdom for a fundamental overhaul of addiction treatment systems.
Iwamasa admitted to administering multiple doses of ketamine to Perry over a three-day period without medical supervision. On the day of Perry's death, the assistant injected the 'Friends' star with at least three shots before leaving the residence. Medical examiners ruled the cause of death as acute effects of ketamine, with drowning listed as a contributing factor. Prosecutors described Iwamasa as a willing participant who exploited his access to Perry for financial gain, though his defence argued he was a loyal employee caught in the actor's spiralling addiction.
Across the Atlantic, British addiction charities have seized on the case to highlight what they describe as a fragmented and underfunded system that fails to address the root causes of substance abuse. 'The tragedy of Matthew Perry is not an isolated Hollywood story. It reflects a global failure to treat addiction as a chronic health condition rather than a moral failing,' said Dr. Helena Blackwood, director of the UK-based Addiction Reform Network. Charities including Turning Point and Action on Addiction have renewed their calls for the government to implement a cross-departmental strategy that integrates mental health services, housing support, and employment assistance.
Perry's death has intensified scrutiny of the medical establishment's role in enabling addiction. The actor had been open about his decades-long struggle with opioids and alcohol, but his death was attributed to an illicit network of doctors and dealers who supplied him with ketamine under the guise of depression treatment. In the UK, where a national health service offers some safeguards, critics argue that privatised addiction clinics often operate with minimal oversight. 'The case exposes how easily patients with resources can access substances under the radar. We need mandatory reporting of high-dose ketamine prescriptions and a centralised registry to prevent doctor shopping,' said Blackwood.
Political reaction in London has been measured but pointed. A spokesperson for the Department of Health and Social Care acknowledged 'ongoing challenges' but insisted that community-based treatment services have received record funding. However, opposition MPs from Labour and the Liberal Democrats have accused the government of complacency, citing a 20 per cent rise in ketamine-related deaths in England since 2019. The Liberal Democrats have tabled a motion calling for a royal commission on addiction, modelled on the approach taken with drug policy in Portugal.
The Iwamasa sentencing also brings a procedural coda to a case that saw five other individuals charged, including two doctors and an alleged dealer. All have since pleaded guilty. The judge emphasised that the sentence was intended to deter similar behaviour, noting that 'this is a cautionary tale of what happens when boundaries are crossed'.
For the UK charities, the Perry case is a catalyst. 'We cannot allow another high-profile death to be met with nothing but headlines. We need structural change,' added Blackwood. The government has promised to publish a new drug and alcohol strategy before the end of the parliamentary term.
